He Junli — SEC insider filings
SEC reporting owner CIK 1728598. 22 insider filings on record with FilingPulse; latest filed 2026-09-25.
Transaction summary — filings shown
Covers all 22 filings on record, filed 2021-11-10 to 2026-09-25. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 15 legs across 14 filings — 414,205 shares, $539,690 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 135 shares, $922 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
- Largest priced transaction: purchase of 361,905 shares @ $1.05 ($380,000) in Harvard Apparatus Regenerative Technology, Inc., filed 2026-09-25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Harvard Apparatus Regenerative Technology, Inc. (HRGN) | CEO, Director | 22 | 15 legs · 414,205 sh · $539,690 | 1 leg · 135 sh · $922 | 15 |
Insider filings — He Junli
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-25 | 4 | Harvard Apparatus Regenerative Technology, Inc. (HRGN) | Conversion (C): 683,725 @ $1.05 · Purchase (P): 361,905 @ $1.05 · Purchase (P): 6,725 @ $2.15 · Conversion (C): 310,000 (derivative) · Conversion (C): 205,378 (derivative) · Conversion (C): 202,533 (derivative) | EDGAR |
| 2026-08-11 | 4 | Harvard Apparatus Regenerative Technology, Inc. (HRGN) | Grant/award (A): 600,000 (derivative) @ $0 · Grant/award (A): 600,000 (derivative) @ $0 | EDGAR |
| 2025-12-01 | 4 | Harvard Apparatus Regenerative Technology, Inc. (HRGN) | Purchase (P): 3,000 @ $1.70 | EDGAR |
| 2025-10-01 | 4 | Harvard Apparatus Regenerative Technology, Inc. (HRGN) | Purchase (P): 300 @ $1.98 | EDGAR |
| 2025-09-24 | 4 | Harvard Apparatus Regenerative Technology, Inc. (HRGN) | Purchase (P): 11,225 @ $1.85 | EDGAR |
| 2025-09-02 | 4 | Harvard Apparatus Regenerative Technology, Inc. (HRGN) | Purchase (P): 4,050 @ $1.72 | EDGAR |
| 2025-01-02 | 4 | Harvard Apparatus Regenerative Technology, Inc. (HRGN) | Purchase (P): 2,299 @ $2.87 | EDGAR |
| 2024-09-12 | 4 | Harvard Apparatus Regenerative Technology, Inc. (HRGN) | Purchase (P): 5,101 @ $3.37 | EDGAR |
| 2024-07-02 | 4 | Harvard Apparatus Regenerative Technology, Inc. (HRGN) | Purchase (P): 1,600 @ $2.80 | EDGAR |
| 2024-01-12 | 4 | Harvard Apparatus Regenerative Technology, Inc. (HRGN) | Grant/award (A): 220,640 (derivative) @ $0 | EDGAR |
| 2024-01-03 | 4 | Harvard Apparatus Regenerative Technology, Inc. (HRGN) | Purchase (P): 2,700 @ $4.76 | EDGAR |
| 2023-12-18 | 4 | Harvard Apparatus Regenerative Technology, Inc. (HRGN) | Purchase (P): 900 @ $4.92 | EDGAR |
| 2023-12-11 | 4 | Harvard Apparatus Regenerative Technology, Inc. (HRGN) | Purchase (P): 1,500 @ $5.07 | EDGAR |
| 2023-09-18 | 4 | Harvard Apparatus Regenerative Technology, Inc. (HRGN) | Purchase (P): 1,500 @ $5.43 | EDGAR |
| 2023-09-05 | 4 | Harvard Apparatus Regenerative Technology, Inc. (HRGN) | Purchase (P): 3,400 @ $4.69 | EDGAR |
| 2023-08-28 | 4 | Harvard Apparatus Regenerative Technology, Inc. (HRGN) | Purchase (P): 8,000 @ $4.32 | EDGAR |
| 2023-07-10 | 4/A | Biostage, Inc. (BSTG) | Grant/award (A): 267,616 (derivative) @ $0 | EDGAR |
| 2023-04-12 | 4 | Biostage, Inc. (BSTG) | Grant/award (A): 732,384 (derivative) @ $0 · Grant/award (A): 488,256 (derivative) @ $0 | EDGAR |
| 2023-01-05 | 4 | Biostage, Inc. (BSTG) | Sale (S): 135 @ $6.83 | EDGAR |
| 2022-07-01 | 4 | Biostage, Inc. (BSTG) | Grant/award (A): 6,241 (derivative) @ $0 · Grant/award (A): 5,016 (derivative) @ $0 | EDGAR |
| 2022-05-20 | 4 | Biostage, Inc. (BSTG) | Grant/award (A): 6,813 (derivative) @ $0 | EDGAR |
| 2021-11-10 | 4 | Biostage, Inc. (BSTG) | Grant/award (A): 10,895 (derivative) @ $0 · Grant/award (A): 8,727 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-11-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1728598 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs